Integrin α3β1 controls mRNA splicing that determines Cox-2 mRNA stability in breast cancer cells

Journal of Cell Science

Volumn 127, Issue 6, 2014, Pages 1179-1189

  Subbaram, Sita ^a   Lyons, Scott P ^a   Svenson, Kimberly B ^a   Hammond, Sean L ^a   McCabe, Lorena G ^a   Chittur, Sridar V ^b   Dipersio, C Michael ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

3 1 integrin; Alternative splicing; Breast cancer; Cox 2; Nonsense mediated mRNA decay

Indexed keywords

CYCLOOXYGENASE 2; VERY LATE ACTIVATION ANTIGEN 3; LAMININ; MESSENGER RNA; PROTEIN BINDING; PTGS2 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSCRIPTOME; UPF1 PROTEIN, HUMAN;

ADENOVIRUS INFECTION; ALTERNATIVE RNA SPLICING; ARTICLE; BREAST CANCER; CANCER CELL; COMPARATIVE STUDY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION; IMMUNOBLOTTING; LENTIVIRUS INFECTION; NONHUMAN; NONSENSE MEDIATED MRNA DECAY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; RNA DEGRADATION; RNA SPLICING; TUMOR GROWTH; TUMOR MICROENVIRONMENT; WESTERN BLOTTING; AMINO ACID SEQUENCE; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTRON; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; TUMOR CELL LINE;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHA3BETA1; INTRONS; LAMININ; MOLECULAR SEQUENCE DATA; NONSENSE MEDIATED MRNA DECAY; PROTEIN BINDING; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTOME;

EID: 84903362152     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.131227     Document Type: Article

References (57)

1. Akool, S., Kleinert, H., Hamada, F. M., Abdelwahab, M. H., Förstermann, U., Pfeilschifter, J. and Eberhardt, W. (2003). Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNAstabilizing factor HuR. Mol. Cell. Biol. 23, 4901-4916.
2. Bhuvanagiri, M., Schlitter, A. M., Hentze, M. W. and Kulozik, A. E. (2010). NMD: RNA biology meets human genetic medicine. Biochem. J. 430, 365-377.
3. Brennan, C. M. and Steitz, J. A. (2001). HuR and mRNA stability. Cell. Mol. Life Sci. 58, 266-277.
4. Cagnet, S., Faraldo, M. M., Kreft, M., Sonnenberg, A., Raymond, K. and Glukhova, M. A. (2013). Signaling events mediated by α3β1 integrin are essential for mammary tumorigenesis. Oncogene. [Epub ahead of print] doi:10.1038/onc.2013.391.
5. Carpenter, P. M., Wang-Rodriguez, J., Chan, O. T. and Wilczynski, S. P. (2008). Laminin 5 expression in metaplastic breast carcinomas. Am. J. Surg. Pathol. 32, 345-353.
6. Carpenter, P. M., Dao, A. V., Arain, Z. S., Chang, M. K., Nguyen, H. P., Arain, S., Wang-Rodriguez, J., Kwon, S. Y. and Wilczynski, S. P. (2009). Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5). Mol. Cancer Res. 7, 462-475.
7. Danckwardt, S., Hentze, M. W. and Kulozik, A. E. (2008). 39 end mRNA processing: molecular mechanisms and implications for health and disease. EMBO J. 27, 482-498.
8. Desgrosellier, J. S. and Cheresh, D. A. (2010). Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 10, 9-22.
9. Di Giammartino, D. C., Nishida, K. and Manley, J. L. (2011). Mechanisms and consequences of alternative polyadenylation. Mol. Cell 43, 853-866.
10. DiPersio, C. M., Shah, S. and Hynes, R. O. (1995). alpha 3A beta 1 integrin localizes to focal contacts in response to diverse extracellular matrix proteins. J. Cell Sci. 108, 2321-2336.
11. DiPersio, C. M., Shao, M., Di Costanzo, L., Kreidberg, J. A. and Hynes, R. O. (2000). Mouse keratinocytes immortalized with large T antigen acquire alpha3beta1 integrin-dependent secretion of MMP-9/gelatinase B. J. Cell Sci. 113, 2909-2921.
12. Dixon, D. A., Tolley, N. D., King, P. H., Nabors, L. B., McIntyre, T. M., Zimmerman, G. A. and Prescott, S. M. (2001). Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J. Clin. Invest. 108, 1657-1665.
13. Dutertre, M., Lacroix-Triki, M., Driouch, K., de la Grange, P., Gratadou, L., Beck, S., Millevoi, S., Tazi, J., Lidereau, R., Vagner, S. et al. (2010). Exonbased clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis. Cancer Res. 70, 896-905.
14. Gardner, L. B. (2008). Hypoxic inhibition of nonsense-mediated RNA decay regulates gene expression and the integrated stress response. Mol. Cell. Biol. 28, 3729-3741.
15. Gardner, L. B. (2010). Nonsense-mediated RNA decay regulation by cellular stress: implications for tumorigenesis. Mol. Cancer Res. 8, 295-308.
16. Gehring, N. H., Kunz, J. B., Neu-Yilik, G., Breit, S., Viegas, M. H., Hentze, M. W. and Kulozik, A. E. (2005). Exon-junction complex components specify distinct routes of nonsense-mediated mRNA decay with differential cofactor requirements. Mol. Cell 20, 65-75.
17. Goodman, S. L. and Picard, M. (2012). Integrins as therapeutic targets. Trends Pharmacol. Sci. 33, 405-412.
18. Harper, K. A. and Tyson-Capper, A. J. (2008). Complexity of COX-2 gene regulation. Biochem. Soc. Trans. 36, 543-545.
19. Harris, R. E. (2009). Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung. Inflammopharmacology 17, 55-67.
20. Hogg, J. R. and Goff, S. P. (2010). Upf1 senses 39UTR length to potentiate mRNA decay. Cell 143, 379-389.
21. Hollebeeck, S., Raas, T., Piront, N., Schneider, Y. J., Toussaint, O., Larondelle, Y. and During, A. (2011). Dimethyl sulfoxide (DMSO) attenuates the inflammatory response in the in vitro intestinal Caco-2 cell model. Toxicol. Lett. 206, 268-275.
22. Howe, L. R. (2007). Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer. Breast Cancer Res. 9, 210.
23. Huang, Y. P., Ye, D. Y., Wu, P., Huang, Y. F., Sun, W., Ying, H. G., Pan, Q., Wan, J. Y., Yuan, P. and Zhang, D. J. (2003). [Expression of cyclooxygenase-2 mRNA and identification of its spliceriant in human myometrium obtained from women in labor]. Zhonghua Fu Chan Ke Za Zhi 38, 270-272.
24. Hwang, J. and Maquat, L. E. (2011). Nonsense-mediated mRNA decay (NMD) in animal embryogenesis: to die or not to die, that is the question. Curr. Opin. Genet. Dev. 21, 422-430.
25. Hynes, R. O. (2002). Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687.
26. Iyer, V., Pumiglia, K. and DiPersio, C. M. (2005). Alpha3beta1 integrin regulates MMP-9 mRNA stability in immortalized keratinocytes: a novel mechanism of integrin-mediated MMP gene expression. J. Cell Sci. 118, 1185-1195.
27. Janes, S. M. and Watt, F. M. (2006). New roles for integrins in squamous-cell carcinoma. Nat. Rev. Cancer 6, 175-183.
28. Jang, B. C., Sanchez, T., Schaefers, H. J., Trifan, O. C., Liu, C. H., Creminon, C., Huang, C. K. and Hla, T. (2000). Serum withdrawal-induced posttranscriptional stabilization of cyclooxygenase-2 mRNA in MDA-MB-231 mammary carcinoma cells requires the activity of the p38 stress-activated protein kinase. J. Biol. Chem. 275, 39507-39515.
29. Khabar, K. S. (2010). Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements. Cell. Mol. Life Sci. 67, 2937-2955.
30. Kurokawa, K., Kuwano, Y., Tominaga, K., Kawai, T., Katsuura, S., Yamagishi, N., Satake, Y., Kajita, K., Tanahashi, T. and Rokutan, K. (2010). Brief naturalistic stress induces an alternative splice variant of SMG-1 lacking exon 63 in peripheral leukocytes. Neurosci. Lett. 484, 128-132.
31. Lamar, J. M., Pumiglia, K. M. and DiPersio, C. M. (2008). An immortalizationdependent switch in integrin function up-regulates MMP-9 to enhance tumor cell invasion. Cancer Res. 68, 7371-7379.
32. Lapuk, A., Marr, H., Jakkula, L., Pedro, H., Bhattacharya, S., Purdom, E., Hu, Z., Simpson, K., Pachter, L., Durinck, S. et al. (2010). Exon-level microarray analyses identify alternative splicing programs in breast cancer. Mol. Cancer Res. 8, 961-974.
33. Lykke-Andersen, J., Shu, M. D. and Steitz, J. A. (2000). Human Upf proteins target an mRNA for nonsense-mediated decay when bound downstream of a termination codon. Cell 103, 1121-1131.
34. Margadant, C., Raymond, K., Kreft, M., Sachs, N., Janssen, H. and Sonnenberg, A. (2009). Integrin alpha3beta1 inhibits directional migration and wound re-epithelialization in the skin. J. Cell Sci. 122, 278-288.
35. Mendell, J. T., Sharifi, N. A., Meyers, J. L., Martinez-Murillo, F. and Dietz, H. C. (2004). Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise. Nat. Genet. 36, 1073-1078.
36. Mitchell, K., Szekeres, C., Milano, V., Svenson, K. B., Nilsen-Hamilton, M., Kreidberg, J. A. and DiPersio, C. M. (2009). Alpha3beta1 integrin in epidermis promotes wound angiogenesis and keratinocyte-to-endothelial-cell crosstalk through the induction of MRP3. J. Cell Sci. 122, 1778-1787.
37. Mitchell, K., Svenson, K. B., Longmate, W. M., Gkirtzimanaki, K., Sadej, R., Wang, X., Zhao, J., Eliopoulos, A. G., Berditchevski, F. and Dipersio, C. M. (2010). Suppression of integrin alpha3beta1 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells. Cancer Res. 70, 6359-6367.
38. Moore, A. E., Young, L. E. and Dixon, D. A. (2011). MicroRNA and AU-rich element regulation of prostaglandin synthesis. Cancer Metastasis Rev. 30, 419-435.
39. Morini, M., Mottolese, M., Ferrari, N., Ghiorzo, F., Buglioni, S., Mortarini, R., Noonan, D. M., Natali, P. G. and Albini, A. (2000). The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int. J. Cancer 87, 336-342.
40. Nicholson, P., Yepiskoposyan, H., Metze, S., Zamudio Orozco, R., Kleinschmidt, N. and Mühlemann, O. (2010). Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors. Cell. Mol. Life Sci. 67, 677-700.
41. Pontes-Júnior, J., Reis, S. T., de Oliveira, L. C., Sant'anna, A. C., Dall'oglio, M. F., Antunes, A. A., Ribeiro-Filho, L. A., Carvalho, P. A., Cury, J., Srougi, M. et al. (2010). Association between integrin expression and prognosis in localized prostate cancer. Prostate 70, 1189-1195.
42. Rossetti, G., Collinge, M., Bender, J. R., Molteni, R. and Pardi, R. (2002). Integrin-dependent regulation of gene expression in leukocytes. Immunol. Rev. 186, 189-207.
43. Roy, S. W. and Irimia, M. (2008). Intron mis-splicing: no alternative? Genome Biol. 9, 208.
44. Sachs, N., Secades, P., van Hulst, L., Kreft, M., Song, J. Y. and Sonnenberg, A. (2012). Loss of integrin a3 prevents skin tumor formation by promoting epidermal turnover and depletion of slow-cycling cells. Proc. Natl. Acad. Sci. USA 109, 21468-21473.
45. Scales, T. M., Jayo, A., Obara, B., Holt, M. R., Hotchin, N. A., Berditchevski, F. and Parsons, M. (2013). α3βb1 integrins regulate CD151 complex assembly and membrane dynamics in carcinoma cells within 3D environments. Oncogene 32, 3965-3979.
46. Shi, C., Zhang, X., Chen, Z., Sulaiman, K., Feinberg, M. W., Ballantyne, C. M., Jain, M. K. and Simon, D. I. (2004). Integrin engagement regulates monocyte differentiation through the forkhead transcription factor Foxp1. J. Clin. Invest. 114, 408-418.
47. Singh, G., Rebbapragada, I. and Lykke-Andersen, J. (2008). A competition between stimulators and antagonists of Upf complex recruitment governs human nonsense-mediated mRNA decay. PLoS Biol. 6, e111.
48. Singh-Ranger, G., Salhab, M. and Mokbel, K. (2008). The role of cyclooxygenase-2 in breast cancer: review. Breast Cancer Res. Treat. 109, 189-198.
49. Subbaram, S. and DiPersio, C. M. (2011). Integrin α3β1 as a breast cancer target. Expert Opin. Ther. Targets 15, 1197-1210.
50. Sugiura, T. and Berditchevski, F. (1999). Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2). J. Cell Biol. 146, 1375-1389.
51. Symington, B. E. and Carter, W. G. (1995). Modulation of epidermal differentiation by epiligrin and integrin alpha 3 beta 1. J. Cell Sci. 108, 831-838.
52. Wang, H., Fu, W., Im, J. H., Zhou, Z., Santoro, S. A., Iyer, V., DiPersio, C. M., Yu, Q. C., Quaranta, V., Al-Mehdi, A. et al. (2004). Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. J. Cell Biol. 164, 935-941.
53. Wang, D., Zavadil, J., Martin, L., Parisi, F., Friedman, E., Levy, D., Harding, H., Ron, D. and Gardner, L. B. (2011). Inhibition of nonsense-mediated RNA decay by the tumor microenvironment promotes tumorigenesis. Mol. Cell. Biol. 31, 3670-3680.
54. Welch, E. M., Barton, E. R., Zhuo, J., Tomizawa, Y., Friesen, W. J., Trifillis, P., Paushkin, S., Patel, M., Trotta, C. R., Hwang, S. et al. (2007). PTC124 targets genetic disorders caused by nonsense mutations. Nature 447, 87-91.
55. Xiao, G., Wang, D., Benson, M. D., Karsenty, G. and Franceschi, R. T. (1998). Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J. Biol. Chem. 273, 32988-32994.
56. Zhang, X. P., Puzon-McLaughlin, W., Irie, A., Kovach, N., Prokopishyn, N. L., Laferté, S., Takeuchi, K., Tsuji, T. and Takada, Y. (1999). Alpha 3 beta 1 adhesion to laminin-5 and invasin: critical and differential role of integrin residues clustered at the boundary between alpha 3 N-terminal repeats 2 and 3. Biochemistry 38, 14424-14431.
57. Zhang, F., Tom, C. C., Kugler, M. C., Ching, T. T., Kreidberg, J. A., Wei, Y. and Chapman, H. A. (2003). Distinct ligand binding sites in integrin alpha3beta1 regulate matrix adhesion and cell-cell contact. J. Cell Biol. 163, 177-188.